Company profile: IMS
1.1 - Company Overview
Company description
- Provider of analytic services, data management, application development, web services, and cloud computing and hosting support, with 40+ years of IT and clinical trials experience. Develops software products and web applications supporting biomedical research for clients including the National Cancer Institute, the Centers for Disease Control and Prevention, and major pharmaceutical firms.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IMS
ePharma Solutions
HQ: United States
Website
- Description: Provider of e-clinical solutions that help sponsors, pharmaceutical companies, CROs, and investigator sites accelerate and improve clinical studies through better site selection, training, activation, and management. Offerings include Site Feasibility to find and activate qualified sites globally, and Rater and Patient Training to mitigate bias and variability, improving data quality and standardization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ePharma Solutions company profile →
EmergingMed
HQ: United States
Website
- Description: Provider of clinical trial enrollment optimization solutions, offering a Clinical Trial Navigation Service that helps patients find trials matching their diagnosis and treatment history using a national database of cancer treatment trials, and a comprehensive Trial Database covering all treatment trials from clinicaltrials.gov with additional updates from trial sponsors and sites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EmergingMed company profile →
CTS Database
HQ: United States
Website
- Description: Provider of a clinical trial subject registry that preserves the privacy and security of research subjects while providing sponsors and investigators with crucial information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTS Database company profile →
Complion
HQ: United States
Website
- Description: Provider of an eRegulatory digital platform for clinical research sites, enabling administrators and research coordinators to more efficiently maintain compliance protocols, supporting investigators with fewer hassles, and streamlining crucial information for auditors and quality assurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Complion company profile →
Lindy Biosciences
HQ: United States
Website
- Description: Provider of protein therapeutic formulation technologies, including Microglassification™ to create solid amorphous microbeads for stable long-term storage and subcutaneous delivery; high-concentration biologic formulations that reduce viscosity and increase stability for subcutaneous dosing of monoclonal antibodies; and MG Suspensions offering a subcutaneous alternative to intravenous infusions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lindy Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IMS
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IMS
2.2 - Growth funds investing in similar companies to IMS
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IMS
4.2 - Public trading comparable groups for IMS
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →